Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2021-04-11 Board/Management Inform…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
PEB CEO, David Darling, Announces Intention to Retire
Board/Management Information Classification · 100% confidence The document is a company announcement dated 12 April 2021, regarding the CEO David Darling's intention to retire and the board's plans to appoint a successor. It contains no financial data, no regulatory form references, no voting results, no legal proceedings, no financial results, and no report attachments. The content is focused on management change and succession planning. Therefore, it fits the category of Board/Management Information (MANG). The document length is 5248 characters, which is sufficient for a detailed announcement but does not contain financial or regulatory report content.
2021-04-11 English
Pacific Edge Limited (“PEB”) – Trading Halt Lifted
Regulatory Filings Classification · 95% confidence The document is a short memorandum from NZX Limited regarding the lifting of a trading halt on Pacific Edge Limited's securities. It is a brief market announcement about trading status, not a financial report, management update, or regulatory filing with substantive content. The document length is only 666 characters, indicating it is a short notice rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-09 English
United Healthcare Issues Positive Coverage Cxbladder
Regulatory Filings Classification · 95% confidence The document is an announcement from Pacific Edge Limited regarding a positive coverage decision by United Healthcare for their Cxbladder diagnostic tests. It provides background information about the company and its products, but does not contain financial statements, detailed financial performance data, or regulatory filings. The document is a corporate announcement about a business development (insurance coverage approval) rather than a financial report or regulatory filing. It is not an earnings release, annual report, or any other detailed financial or governance report. Therefore, it fits best into the category of Regulatory Filings (RNS) as a general announcement that does not fit into other specific categories.
2021-04-09 English
Pacific Edge Limited (“PEB”) – Trading Halt of Securities
Regulatory Filings Classification · 95% confidence The document is a memorandum from NZX Limited announcing a trading halt on Pacific Edge Limited's securities. It is a short notice about market trading status, not a financial report, management change, or any detailed filing. It does not contain financial data, voting results, or regulatory certifications. It is a regulatory announcement related to trading status, which fits best under Regulatory Filings (RNS).
2021-04-09 English
PEB Concludes Commercial Agreement with Facey Medical Group
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 31 March 2021 about Pacific Edge Limited concluding a commercial agreement with Facey Medical Group in the US. It describes the nature of the agreement and provides background information about the company and its products. There is no financial data, no regulatory filing references, no voting results, no management or board changes, no earnings or interim report data, and no mention of any report publication or certification. The content is a straightforward commercial agreement announcement, which does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the nature of the content, the best fitting category is a general Regulatory Filing (RNS), which serves as a fallback for miscellaneous announcements that do not fit other specific categories. The document length is under 5,000 characters, but it is not announcing a report publication or attaching a report, so it is not RPA. Confidence is high due to clear content type and absence of financial or regulatory report data.
2021-03-30 English
D&O Ongoing Disclosure – David Darling
Regulatory Filings
2021-03-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.